✦ LIBER ✦

Phase I Study of Neratinib in Combination With Temsirolimus in Patients With Human Epidermal Growth Factor Receptor 2-Dependent and Other Solid Tumors

✍ Scribed by Gandhi, L.; Bahleda, R.; Tolaney, S. M.; Kwak, E. L.; Cleary, J. M.; Pandya, S. S.; Hollebecque, A.; Abbas, R.; Ananthakrishnan, R.; Berkenblit, A.; Krygowski, M.; Liang, Y.; Turnbull, K. W.; Shapiro, G. I.; Soria, J.-C.

Book ID: 127139945
Publisher: American Society of Clinical Oncology
Year: 2014
Tongue: English
Weight: 521 KB
Volume: 32
Category: Article
ISSN: 0732-183X
DOI: 10.1200/jco.2012.47.2787

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I study of temsirolimus in combina

Phase I study of temsirolimus in combination with EKB-569 in patients with advanced solid tumors

✍ Alan H. Bryce, Ravi Rao, Jann Sarkaria, Joel M. Reid, Yingwei Qi, Rui Qin, C. Da 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 236 KB

1247 Phase I study of nimotuzumab, a hum

1247 Phase I study of nimotuzumab, a humanized anti-epidermal growth factor receptor (EGFR) IgG1 monoclonal antibody in Japanese patients with solid tumors

✍ N. Boku; K. Yamazaki; A. Fukutomi; T. Takahashi; N. Yamamoto; M. Miyazaki; T. Sa 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Phase I Active Immunotherapy With Combin

Phase I Active Immunotherapy With Combination of Two Chimeric, Human Epidermal Growth Factor Receptor 2, B-Cell Epitopes Fused to a Promiscuous T-Cell Epitope in Patients With Metastatic and/or Recurrent Solid Tumors

✍ Kaumaya, P. T.P.; Foy, K. C.; Garrett, J.; Rawale, S. V.; Vicari, D.; Thurmond, 📂 Article 📅 2009 🏛 American Society of Clinical Oncology 🌐 English ⚖ 217 KB

Phase I and pharmacokinetic study of UCN

Phase I and pharmacokinetic study of UCN-01 in combination with irinotecan in patients with solid tumors

✍ Antonio Jimeno; Michelle A. Rudek; Thomas Purcell; Daniel A. Laheru; Wells A. Me 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 438 KB

A phase Ib combination study of RO492909

A phase Ib combination study of RO4929097, a gamma-secretase inhibitor, and temsirolimus in patients with advanced solid tumors

✍ Ivan Diaz-Padilla, Hal Hirte, Amit M. Oza, Blaise A. Clarke, Brenda Cohen, Micha 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 344 KB

A phase-I trial of the epidermal growth

A phase-I trial of the epidermal growth factor receptor directed bispecific antibody MDX-447 without and with recombinant human granulocyte-colony stimulating factor in patients with advanced solid tumors

✍ Matthew G. Fury; Allan Lipton; Katherine M. Smith; Corinne B. Winston; David G. 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 377 KB